Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Strengthens Marketing Position for Its Sleep Apnea Program By Signing Agreement with CPAP Supply USA, LLC

TAMPA, Fla., Dec. 29, 2014 /PRNewswire/ -- Advanzeon Solutions, Inc. (OTC:BB:CHCR), ("Advanzeon" or the "Company"), which provides behavioral health, wellness, pharmacy management services and sleep apnea programs, to employers, Taft-Hartley health and welfare funds, managed care companies throughout the U.S. today announced that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS"), has entered into an agreement (the "Agreement") with CPAP Supply USA, LLC ("CPAP Supply USA").  The Agreement provides for, among other things, "most-favored nation pricing," market protection and complete, full-line product support.  The Agreement is effective immediately and marketing programs have already been put in place for implementation.

Mark Heidt, President of Advanzeon Solutions, Inc., stated, "The sleep apnea market is one of the fastest growing markets in healthcare today.  Globally, sleep apnea diagnostic and therapeutic devices are projected to grow to nearly $6.5 billion by 2019 due to an increase in home sleep tests and advancements in CPAP machines.  In this country alone, while diagnostics lag behind reality, 17% of men and 9% of women are diagnosed with sleep apnea.  We, at Advanzeon, have a particular interest in how it affects a large segment of our market – the Teamsters; and the men and women who drive long hours in large commercial vehicles.  Forty-six percent (46%) of commercial drivers are believed to suffer from sleep apnea.  Testing is essential but generally expensive.  By entering into this relationship with CPAP Supply USA, we, at Advanzeon, have endeavored to create a structure that affords our members the best services, the best equipment, the best diagnostics and literally, the best of everything in the sleep apnea universe, at the most affordable price.  We are confident that our selection of CPAP Supply USA further places us in the lead position to accomplish that goal." 

"We are also pleased to announce that in addition to being able to supply our members with the right equipment and services at the right price, we have commenced assembling a national network of Department of Transportation certified medical examiners.  This program was started immediately following our entering into an agreement with Dr. Jeff Liva (see announcement dated September 29, 2014).  This program is progressing nicely.  There is no ignoring the fact that sleep apnea exists and affects many members of our society.  We are proud of our ability to take the lead in addressing the problem," concluded Mark Heidt.

CPAP Supply USA, stated, "We are excited to enter into this new relationship with PVMS.  As the leading supplier of sleep apnea equipment in the U.S., we are proud of our philosophy of providing the best equipment and the best service at the most affordable prices.  It is a philosophy that we understand is shared with us by PVMS as well.  We look forward to a long and mutually beneficial relationship with PVMS and its market."

About CPAP Supply USA, LLC
Founded in October of 2004, CPAP Supply USA has become one of the nation's leading distributors of CPAP and Bi-level machines, masks and supplies.  Over the years, CPAP Supply USA has expanded equipment choices to patients and clients to include:  CPAP comfort items, cleaning supplies, pillows and more.  CPAP Supply USA has maintained its focus on educating patients, as well as providing them with the best sleep therapy equipment at affordable prices.

About Advanzeon Solutions, Inc.
Established in 1969, Advanzeon provides behavioral health, wellness, pharmacy management and sleep apnea programs, for employers, Taft-Hartley health and welfare Funds, and managed care companies throughout the United States.  Headquartered in Tampa, Florida, the Company focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches that address both the specific needs of clients and changing healthcare industry demands.  For more information, please call 813-288-4808.

Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the current beliefs and expectations of the Company's management, reflect numerous assumptions, and are subject to significant risks and uncertainties, many of which are beyond the Company's control.  If any of these underlying beliefs, expectations or assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

These risk factors include, among others, the ability of the Company to maximize its market share with new pharmacy initiatives, the ability of the Company's new pharmacy cost-savings program to guarantee a 10% or more reduction in pharmacy costs, our ability to achieve expected results from new business and to revolutionize the pharmacy sector of the healthcare industry, the ability to obtain a performance bond on satisfactory terms, the ability of the Company's pharmacy program to promote greater medication adherence without restricting access to needed medications, technological advances, challenges in development of new products and services, new products and services developed by competitors, the Company's ability to provide superior patient care while increasing its business and margins as a result of implementing its pharmacy cost-savings program, general industry conditions and competition, general economic factors, global trends toward health care cost containment, the effect of governmental regulation, including pharmaceutical industry regulation, insurance regulation and health care legislation, varying trends in member pharmacy utilization, increases or variations in cost of care, seasonality, our ability to manage healthcare operating expenses, the profitability (if any) from capitated pharmacy contracts or other products, and the Company's ability to obtain additional financing.

Advanzeon undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Additional risk factors that could cause results to differ materially from those described in the forward-looking statements can be found in the Company's most recent Annual Report on Form 10-K and the Company's other filings with the Securities and Exchange Commission (SEC), which are available at the SEC's website at www.sec.gov. 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/advanzeon-solutions-incs-wholly-owned-subsidiary-pharmacy-value-management-solutions-inc-strengthens-marketing-position-for-its-sleep-apnea-program-by-signing-agreement-with-cpap-supply-usa-llc-300014184.html

SOURCE Advanzeon Solutions, Inc.